Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Catheter Precision Inc VTAK

Technology Scientific & Technical Instruments
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.


NYSEAM:VTAK - Post by User

Catheter Precision Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
  • averagepenniesX
Post by averagepennieson Jan 17, 2024 9:29am
64 Views
Post# 35830905

Catheter Precision’s VIVO System Featured in Electrophysiolo

Catheter Precision’s VIVO System Featured in Electrophysiolo

FORT MILL, SC / ACCESSWIRE / January 17, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a leader in non-invasive 3D mapping for ventricular arrhythmias, announced that their VIVO System was highlighted as part of a case study in the current issue of EP Lab Digest. EP Lab Digest is an educational, monthly publication dedicated to electrophysiology with both print and online content.

"Physicians often present case studies to publications for new and innovative products." Said David Jenkins, CEO of Catheter Precision. "Having a case study selected means that the publication committee believes the work presented by the physicians at NYU is valuable for other electrophysiologists. This case study is unique in that it falls under a physician-initiated study and combines two different mapping platforms further streamlining the benefits of pre-procedural planning."

 

https://www.accesswire.com/825550/catheter-precisions-vivo-system-featured-in-electrophysiology-publication

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities